Narita et al.235explored exosome-derived monocyte-derived dendritic cells (moDCs) pulsed with the SART1 peptide for treating esophageal squamous cell carcinoma, while Dai et al.236used ascites-derived exosomes (Aex) in combination with GM-CSF for colorectal cancer (CRC) immunotherapy. This evidence concerns the gene CSF2 and colorectal carcinoma.